In a major effort to develop genome interpretation for the rare disease diagnostics, Genomenon, a top genomic research company, and Diploid, a prominent AI-based software company for rare disease diagnostics, have reportedly inked a partnership deal. Sources with the knowledge of the matter stated that …
The FDA will decide on the definitive approval by the 19th of August 2019. The U.S. Food & Drug Administration (FDA) has reportedly accepted the BLA (Biologics License Application) submitted by the Swiss multinational healthcare company, Roche. The company has been officially granted Priority Review …
Glenmark Pharmaceuticals, the Mumbai-headquartered pharmaceutical company, has made it to the front page for receiving the USFDA (United States Food & Drug Administration) nod for its generic version of skin inflammation treatment foam, Olux foam 0.05 per cent of Mylan Pharmaceuticals. As per IQVIA sales …
Shenzhen Chipscreen Biosciences Ltd., a leading China-based integrated biotech company, has reportedly entered into a collaboration agreement with Innovent Biologics Inc., a Chinese development-stage biopharmaceutical company, in a major effort to evaluate the tolerability and safety of the combination therapy involving Innovent’s Sintilimab and Chipscreen’s …
AbCellera Biologics Inc., the antibody therapeutics developer based in Vancouver, has reportedly entered into a multi-year, multi-target partnership agreement with Novartis International AG, the Swiss multinational pharmaceutical company. Reportedly, the agreement entails the identification of antibodies for about ten therapeutic targets in the pipeline of …
Nano Graphene Inc. (also known as GrapheneCA), a US-based supplier of graphene-based materials, has reportedly announced its plans to make graphene readily available for use in the cosmetics and pharmaceutical industries. Reportedly, GrapheneCA’s latest move helps in paving the path for the introduction & licensing …
GfK, Germany’s largest market research company, and SymphonyAI (SAI), a group of leading AI solution providers, have reportedly partnered for a joint venture (JV) that will be recognized as MRI-Simmons. Reportedly, GfK will combine its MRI division with SAI’s Simmons Research for the joint venture, …
IBM is expected to offer blockchain technologies to make sure that transparency and trust are integrated in the trial process. The American tech giant IBM’s Canadian unit has reportedly joined forces with the German pharmaceutical company, Boehringer Ingelheim GmbH, in a major effort to integrate …
The globally reputed Aurobindo Pharma, based in Hyderabad, has apparently made it to the front page for having categorically closed the acquisition of Apotex’s commercial operations in addition to a select few supporting infrastructure across five major countries in Europe. As per sources familiar with …
